CROSS SECTIONAL STUDY OF COMMUNICABLE DISEASES SURVEILLANCE SYSTEM

Journal Title: World Journal of Pharmaceutical Research - Year 2018, Vol 7, Issue 4

Abstract

Back ground: Surveillance of infectious disease is recognized as the cornerstone of public health decision-making and practice. Surveillance data are crucial for monitoring the health status of the population, detecting diseases and triggering action to prevent further illness, and to contain public health problems. Objectives: The general objective of this study is to assess the core activities supportive functions of the communicable surveillance system in term of structure, performance, epidemic preparedness and response in all health in facility levels in Baghdad. Method: A cross-sectional study conducted at 50 health facilities (Primary Health Centers) which randomly selected (stratified sample) in Baghdad and from both directorates were health (Karkh and Russafa) and Communicable Diseases Control Center of Iraq, from the first of November 2014 till the first of February 2015. The data collected by direct interview with the managers of Surveillance Units, observation of records and documents, materials and equipment by using World Health Organization generic questionnaires for assessment of National communicable disease surveillance. Results: The results showed that National Surveillance Manual was present in 6% of health centers only. Data reporting was very good achieving a rate of 95% of reporting. Data analysis scored 80% but lack the ability to conduct line graphs for communicable diseases, epidemic preparedness was more than the recommended standard indictors (80%), Also 72% was the achievement of Epidemic response in health centers. Feedback was less than standards just 66% of total achievement had achieved. Supervision on surveillance system was present in 65% of health centers The poorest results in this study was training (30%) and resources (21%) for health facilities level. The next levels both, district and central level had achieved very good rate except in resources domain. Conclusion: In conclusion and according to the findings of the study, the surveillance system in Baghdad is good in some parameters and weak in the others (which are Training, Resources and expertise).

Authors and Affiliations

Dr. Suhair Mohammed Hussoon

Keywords

Related Articles

SOLID STATE SINTERING: A NOVEL TECHNIQUE FOR CONTROLLED RELEASE

Sintering is defined as the bonding of adjacent particle surfaces in a mass of powder or in a compact by application of heat. This concept in pharmaceutical science is relatively recent, but research interests relating t...

LIFE STYLE DISORDER AND IT’S MANAGMENT IN AYURVEDA

Ayurveda fullfils multidimensional health needs of human being. As the civilization moves ahead, some threatening disorders are emerging out due to deranged life style. These disorders are commonly caused by excessive al...

HERBAL FLAVONOIDS IN TREATMENT OF HEPATIC DISEASES: A REVIEW

Liver is a vital organ of paramount importance which is the largest glandular organ in the body, located under the diaphragm in the upper right abdomen. In the anatomy and physiology the parts which make up liver are lob...

CAN GARCINIA COCHINCHINENSIS CHOISY AFFECT FOOD INTAKE AND BEHAVIOR IN EXPERIMENTAL MODELS?

Studies have demonstrated an intrinsic relationship between obesity and anxiety, highlighting anxiety as both a frequent symptom among the obese and its strong relationship with an increase in food consumption. The objec...

QUALITY ANALYSIS OF DIFFERENT MARKETED BRANDS OF ATENOLOL (50 MG) TABLETS AVAILABLE IN SYRIA AND COMPARING WITH THE REFERENCE DRUG

There are numerous generics of atenolol tablets available in Syria. The purpose of current study is to assess the physicochemical characters of four brands(A, B, C, D) of atenolol(50mg) tablets advertised in Syria and co...

Download PDF file
  • EP ID EP620566
  • DOI -
  • Views 89
  • Downloads 0

How To Cite

Dr. Suhair Mohammed Hussoon (2018). CROSS SECTIONAL STUDY OF COMMUNICABLE DISEASES SURVEILLANCE SYSTEM. World Journal of Pharmaceutical Research, 7(4), 46-55. https://europub.co.uk/articles/-A-620566